| nov | sp new species [Lat. novum species] |
|---|---|
| SPEC | specificity |
| IRS | immunoreactive secretion; infrared spectrophotometry; insulin receptor species; insulin receptor sub... |
| ROS | reactive oxygen species; review of systems; rod outer segment |
| Sp | the most posterior point on the posterior contour of the sella turcica; species; specific; specimen;... |
| CPSF | Cleavage and polyadenylation specificity factor |
|---|---|
| SP | Specificity |
| SPEC | specificity |
| AOS | Active oxygen species |
| ROS | Radical oxygen species |
| species specificity | Restriction of a characteristic or response to the members of one species; it usually refers to that property of the immune response which differentiates one species from another on the basis of antigen recognition, but the concept is not limited to immunology and is used loosely at levels higher than the species. (12 Dec 1998) |
|---|
| analytical specificity | Freedom from interference by any element or compound other than the analyte. (05 Mar 2000) |
|---|---|
| antibody specificity | The property of antibodies which enables them to react with some antigenic determinants and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. (12 Dec 1998) |
| biological specificity | <biology, zoology> The specific, orderly patterns of development and metabolism which define and characterise an individual and its species. (21 Mar 1998) |
| relative specificity | The specificity of a medical screening test as determined by comparison with the same type of test (e.g., specificity of a new serological test relative to specificity of an established serological test). (05 Mar 2000) |
| sensitivity and specificity | Measures for assessing the results of diagnostic and screening tests. Sensitivity represents the proportion of truly diseased persons in a screened population who are identified as being diseased by the test. It is a measure of the probability of correctly diagnosing a condition. Specificity is the proportion of truly nondiseased persons who are so identified by the screening test. It is a measure of the probability of correctly identifying a nondiseased person. (12 Dec 1998) |
| specificity | The ability of the immune response to interact with individual antigens. (09 Oct 1997) |
| specificity constant | Ratio of the maximum velocity (Vmax) or kcat to the true Km value for a specific substrate in an enzyme-catalyzed reaction. (05 Mar 2000) |
| substrate specificity | A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. (12 Dec 1998) |
| diagnostic specificity | The probability (P) that, given the absence of disease (D), a normal test result (T) excludes disease; i.e., P(T/D). (05 Mar 2000) |
| organ specificity | Restriction of a characteristic or response to a particular organ of the body; it usually refers to that property of the immune response which differentiates one organ from another on the basis of antigen recognition, but the concept is not limited to immunology. (12 Dec 1998) |
| candidate species | <ecology> Any species or subspecies of bird, mammal, fish, amphibian, reptile, or plant that is being considered for listing as endangered or threatened but is not yet the subject of a proposed rule. (16 Dec 1997) |
| management indicator species | A species whose habitat requirements most reflect those of the species community in the habitat of concern, usually used to indicate habitat quality and to predict future conditions. (09 Oct 1997) |
| rare species | A species of animal or plant that is considered rare, threatened, or endangered. (17 Dec 1997) |
| reactive oxygen species | Reactive intermediate oxygen species including both radicals and non-radicals. These substances are constantly formed in the human body and have been shown to kill bacteria and inactivate proteins, and have been implicated in a number of diseases. Scientific data exist that link the reactive oxygen species produced by inflammatory phagocytes to cancer development. (12 Dec 1998) |
| mid seral species | Shade intolerant species, primarily Douglas-fir trees and vine maple shrubs. These species typically follow the early seral species in natural succession. (05 Dec 1998) |
Synonyms : Species Specificities, Specificities, Species, Specificity, Species
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|